Skip to content
HOME discovery services modalities ipsc platform rna therapeutics

Advancing RNA Therapy with Higher Confidence

Bringing human biology into the discovery of RNA therapeutics can be
easily achieved by using the iPSC-based Ncardia platform

Contact us

We help you select the most promising RNA therapeutic candidate earlier with our robust iPSC-platform

The potential of RNA therapeutics, such as small interfering RNA (siRNA), messenger RNA (mRNA), antisense oligonucleotides (ASOs), and microRNA (miRNA), can be hindered by low specificity, risk of off-target effects, challenging delivery or limited clinical translation.

Human induced pluripotent stem cell (iPSC) technology offers a powerful platform for addressing those key challenges by bringing in translational disease models and screening assays. Additionally, iPSC-derived cells can be patient-specific, a key aspect to success in the development of therapies for rare diseases.  

Benefits of Ncardia Solutions

We facilitate your decision-making steps during the selection of RNA therapeutics by integrating human models and clinically relevant readouts 

High Reproducibility

Consistent results with our optimized assays

Predictive Responses

Testing on relevant
human biology

Quick Turnaround

A team focused on timely delivery of reliable data

What we can do for you

We harness our expertise in human biology and iPSC technology to offer robust miniaturized assays for: 

  • Optimize delivery strategies
  • Enhance cellular uptake
  • Assess early pharmacology and predict efficacy 
  • Minimize the chances of late-stage toxicity

Whether you opt for our ready-to-use assays or require a custom solution, our expert team is ready to assist you. 

ASO screening


Neuro ASOs

Download this poster to learn more about our iPSC platform for RNA therapeutics

Related topics

 

Contact Us

If you're ready to explore how to accelerate the discovery of RNA therapeutics with a leading iPSC-based platform, we'd welcome the opportunity to introduce you to Ncardia.

Asha Das, PhD Senior Project Manager
Asha 2